Survey Finds 30% of Independent Pharmacies Will Not Stock Certain IRA-Negotiated Drugs
New data released by the National Community Pharmacists Association (NCPA) finds that roughly 30 percent…
Browsing: Federal
Aimed Alliance Pushes for Transparency in AI Prior Authorization Decisions
Aimed Alliance submitted written testimony regarding Washington’s Senate Bill 5395 and House Bill 1566, which…
Aimed Alliance Advocates for Clarifications to WA Obesity Treatment Access Legislation
In February 2025, Aimed Alliance submitted a comment on Washington Senate Bill 5353, which would…
Aimed Alliance Urges Patient-Focused Amendments to MD PDAB Bill
Aimed Alliance provided comments on Maryland’s SB0357/HB0424, legislation that would enable the Maryland Prescription Drug…
DOL Confirms FMLA Can Be Used For Clinical Trial Participation
In November 2024, the Department of Labor (DOL) issued an advisory opinion confirming the Family…
Aimed Alliance Comments on 2026 Proposed Changes to Medicare & Medicaid
On January 27, 2025, Aimed Alliance submitted a comment on the Centers for Medicare &…
Aimed Alliance Urges CMS to Finalize Coverage of Obesity Treatments Proposed Rule
On January 27, 2025, Aimed Alliance commented on the Centers for Medicare & Medicaid Services…
Aimed Alliance Supports Missouri Copay Accumulator Ban
On January 22, 2025, Aimed Alliance submitted a letter to the Families, Seniors, and Health…
Report Finds Racial Disparities in Medicare Advantage Physician Networks
A report by the Brown University Center for Advancing Health Policy through Research (CAHPR) highlights…
FTC Second Interim Staff Report Finds PBMs Significantly Mark Up Drugs
On January 14, 2024, the Federal Trade Commission (FTC) released its second report investigating the…